TLCR Reading Tools
How to cite item
Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{47692}, author = {Pavan, A., Boscolo Bragadin, A., Calvetti, L., Ferro, A., Zulato, E., Attili, I., Nardo, G., Dal Maso, A., Frega, S., Menin, A., Fassan, M., Calabrese, F., Pasello, G., Guarneri, V., Aprile, G., Conte, P., Rosell, R., Indraccolo, S., Bonanno, L.}, title = {Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome}, journal = {Translational Lung Cancer Research}, volume = {10}, number = {1}, year = {2020}, url = {https://tlcr.amegroups.org/article/view/47692} }